Bromal-derived tetrahydro-β-carbolines as neurotoxic agents:: Chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration

被引:39
作者
Bringmann, G
Feineis, D
Brückner, R
Blank, M
Peters, K
Peters, EM
Reichmann, H
Janetzky, B
Grote, C
Clement, HW
Wesemann, W
机构
[1] Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany
[2] Max Planck Inst Festkorperforsch, D-70506 Stuttgart, Germany
[3] Tech Univ Dresden, Klinkum Carl Gustav Carus, Neurol Klin & Poliklin, D-01307 Dresden, Germany
[4] Univ Marburg, Neurochem Abt, Inst Physiol Chem, D-35033 Marburg, Germany
关键词
D O I
10.1016/S0968-0896(00)00073-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian alkaloids tryptoline (1) and eleagnine (2) as well as the highly halogenated (X = F, Cl Br) tetrahydro-beta-carbolines (TH beta Cs) 3-5, structurally similar to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 6), were found to have a common feature of inducing a severe impairment of the nigrostriatal dopamine metabolism and inhibiting complex I of the mitochondrial respiratory chain highly selectively. Within the series of compounds tested, 1-tribromomethyl-1,2,3,4-tetrahydro-beta-carboline ('TaBro', 5), which was prepared in high yields from the biogenic amine tryptamine ('Ta', 7) and the unnatural aldehyde bromal ('Bro', 8) by a Pictet-Spengler cyclization reaction, turned out to be the most potent toxin in vitro and in vivo. As demonstrated by voltammetric measurements on rats, for all the TH beta Cs 1-5 investigated, intranigral application of a single dose of 10 mu g resulted in a significant reduction of the dopaminergic activity in the striatum, with the strongest effect being observed for TaBro (5). Using rat brain homogenates, again 5 (IC(50) = 200 CIM) as well as its dehydrohalogenation product 11 (IC(50) = 150 mu M) exhibited the most pronounced inhibitory potential on mitochondrial respiration. The halogen-free TH beta Cs 1 and 2 as well as the MPTP metabolite 1-methyl-4-phenylpyridinium ion (MPP(+)), by contrast, showed only a moderate inhibition at concentrations in the millimolar range (e.g. for MPP(+): IC(50) - 3.5 mM). For an elucidation of the role of hydrophobic portion in the inhibitory action against complex I activity, several N-acyl derivatives (15-21) of 5 were synthesized and tested. An X-ray diffraction study on the 3-dimensional structure of trifluoroacetylated highly halogenated TH beta Cs (12-14) revealed the tetrahydropyrido part to adopt a nearly planarized half-chair conformation. Because of the steric demand of the trihalogenmethyl moiety (CF(3) < CCl(3) < CBr(3)), the N-substituent is dramatically pushed out of that ring 'plane'. (C) 2000 Elsevier science Ltd. All rights reserved.
引用
收藏
页码:1467 / 1478
页数:12
相关论文
共 55 条
[1]  
AIRAKSINEN MM, 1981, MED BIOL, V59, P190
[2]   Synthetic trials on the indol-group, VIII. Synthesis from harman and harmin. [J].
Akabori, S ;
Saito, K .
BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, 1930, 63 :2245-2248
[3]   MITOCHONDRIAL RESPIRATORY INHIBITION BY N-METHYLATED BETA-CARBOLINE DERIVATIVES STRUCTURALLY RESEMBLING N-METHYL-4-PHENYLPYRIDINE [J].
ALBORES, R ;
NEAFSEY, EJ ;
DRUCKER, G ;
FIELDS, JZ ;
COLLINS, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9368-9372
[4]  
Bringmann G, 1995, J NEURAL TRANSM-SUPP, P235
[5]  
Bringmann G, 2000, Z NATURFORSCH B, V55, P94
[6]  
Bringmann G, 1995, J NEURAL TRANSM-SUPP, P245
[7]   ENDOGENOUS ALKALOIDS IN MAN .7. 1-TRICHLOROMETHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE - A POTENTIAL CHLORAL-DERIVED INDOLE ALKALOID IN MAN [J].
BRINGMANN, G ;
HILLE, A .
ARCHIV DER PHARMAZIE, 1990, 323 (09) :567-569
[8]   Endogenous alkaloids in man, part 31.: Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline in human blood after intake of the hypnotic chloral hydrate [J].
Bringmann, G ;
God, R ;
Fähr, S ;
Feineis, D ;
Fornadi, K ;
Fornadi, F .
ANALYTICAL BIOCHEMISTRY, 1999, 270 (01) :167-175
[9]  
Bringmann G, 1996, BIOGENIC AMINES, V12, P83
[10]  
BRINGMANN G, 2000, IN PRESS NEUROCHEM R, V25